---
schema_version: "secwatch.filing_event.v1"
accession: "0000318154-23-000061"
form_type: "8-K"
ticker: "AMGN"
cik: "0000318154"
company_name: "AMGEN INC"
filed_at: "2023-10-31T23:59:59+00:00"
generated_at: "2026-06-09T05:04:27.507907+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Amgen Q3 revenue $6.9B (+4% YoY); GAAP EPS $3.22 (-19%); Non-GAAP EPS $4.96 (+6%)

## Summary
- Total revenues $6.9B (+4% YoY); product sales +5% on 11% volume growth.
- GAAP EPS $3.22 (down 19% YoY), includes ~$650M impairment for discontinued AMG 340.
- Non-GAAP EPS $4.96 (+6% YoY); non-GAAP operating margin 52.0%.
- Free cash flow $2.5B in Q3 vs $2.8B in prior year.

## SEC filing metadata
- accession: 0000318154-23-000061
- form_type: 8-K
- ticker: AMGN
- cik: 0000318154
- company_name: AMGEN INC
- filed_at: 2023-10-31T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318154/000031815423000061/0000318154-23-000061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318154/000031815423000061/amgn-20231031.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000318154-23-000061
- JSON: https://secwatch.observer/filing/0000318154-23-000061.json
- Plain text: https://secwatch.observer/filing/0000318154-23-000061.txt

## Key facts
- Earnings Releases
  AMGEN INC reported third quarter of 2023 results: revenue $6.9 billion.
  - Period: third quarter of 2023
  - Revenue: $6.9 billion
  - Result: reported results
  source text: of the Horizon acquisition, Amgen has added rare disease medicines that fit well with our broad innovative portfolio." Key results include: • Total revenues increased 4% to $6.9 billion in comparison to the third quarter of 2022, resulting from a 5% increase in product sales. Produ ct sales growth was driven by 11% volume growth, partially offset by 3% lower net
  evidence_url: https://www.sec.gov/Archives/edgar/data/318154/000031815423000061/0000318154-23-000061-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.